BRCA1 and cancer: The well-established dysregulation of miRNA expression in cancer, together with the contribution of miRNAs to tumorigenesis and the fact that in BRCA1/2 mutation carriers, the genetic alterations are present in all body cells, offers a probable explanation for a distinct circulating miRNA signature.